|
| |
| | | 65694 | | 17.09.2015 | | Mepha Pharma AG | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Gliclazid-Mepha Teva MR 30 mg | Retardtabletten | Retard-Tabletten (Gliclazidum 30 mg) | A10BB09 | PI | | 02 | Gliclazid-Mepha Teva MR 60 mg | Retardtabletten | Retard-Tabletten (Gliclazidum 60 mg) | A10BB09 | PI |
|
|
|
